Vitamin K3 induces cell cycle arrest and cell death by inhibiting Cdc25 phosphatase

European Journal of Cancer

Volumn 35, Issue 9, 1999, Pages 1388-1393

  Wu, F Y H ^a   Sun, T P ^a  

^a INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

Cdc25 phosphatase; Cyclin A; Cyclin E; Dual specificity phosphatases; Human cervical carcinoma SiHa cells; Vitamin K3

Indexed keywords

CYCLIN A; CYCLIN E; MENADIONE; PHOSPHATASE; CELL CYCLE PROTEIN; PHOSPHOPROTEIN PHOSPHATASE; VITAMIN K GROUP;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CONTROLLED STUDY; DRUG CYTOTOXICITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; APOPTOSIS; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; GENE; PATHOLOGY; PHYSIOLOGY; UTERINE CERVIX TUMOR;

APOPTOSIS; CELL CYCLE; CELL CYCLE PROTEINS; FEMALE; GENES, CDC; HUMANS; PHOSPHOPROTEIN PHOSPHATASE; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS; VITAMIN K;

EID: 0033181209     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(99)00156-2     Document Type: Article

References (34)

1. King R.W., Jackson P.K., Kirshner M.W. Mitosis in transition. Cell. 79:1994;563-571.
2. Heichman K.A., Roberts J. Rules to replicate by. Cell. 79:1994;557-562.
3. Sherr C.J. G1 phase progression: cyclin on cue. Cell. 79:1994;551-555.
4. Pines J. Cyclins and cyclin-dependent kinases: theme and variations. Adv Cancer Res. 66:1995;181-212.
5. Galaktionov K., Beach D. Specific activaton of cdc25 tyrosine phosphatases by B-type cyclins: evidence for multiple roles of mitotic cyclins. Cell. 67:1991;1181-1194.
6. Nagata A., Igarashi M., Jinno S., Suto K., Okayama H. An additional homolog of the fission yeast cdc25+ gene occurs in humans and is highly expressed in some cancer cells. New Biol. 3:1991;959-968.
7. Sadhu K., Reed S.I., Richardson H., Russel P. Human homolog of fission yeast cdc25 mitotic inducer is predominantly expressed in G2. Proc. Natl. Acad. Sci. USA. 87:1990;5139-5143.
8. 2-terminal domain in the catalysis and substrate binding of human Cdc25. J. Biol. Chem. 271:1996;5118-5124.
9. Kakizuka A., Sebastian B., Borgmeyer V.et al. A mouse cdc25 homolog is differentially and developmentally expressed. Genes Dev. 6:1992;578-590.
10. Hoffmann I., Clarke P.R., Marcote M.J., Karsenti E., Draetta G. Phosphorylation and activation of human cdc25-C by cdc2-cyclin B and its involvement in the self-amplification of MPF at mitosis. EMBO J. 12:1993;53-63.
11. 3 (menadione) inhibits the growth of mammalian tumor cells in culture. Life Sci. 29:1981;1387-1392.
12. Nutter L.M., Cheng A.L., Hung H.L., Hsieh R.K., Ngo E.O., Liu T.W. Menadione: spectrum of anticancer activity and effects on nucleotide metabolism in human neoplastic cell lines. Biochem. Pharmacol. 41:1991;1283-1292.
13. 3 on human tumor cells by two (MTT and SRB) cell viability assays. Life Sci. 52:1993;1797-1804.
14. 3 and methotrexate in tumor-bearing animals. Cancer Treat Rep. 70:1986;1433-1435.
15. 3) against rat transplantable hepatoma induced by 3′-methylaminoazobenzene. Kaohsiung J. Med. Sci. 7:1991;454-459.
16. Ngo E.O., Sun T.-P., Chang J.-Y.et al. Menadione-induced DNA damage in a human tumor cell line. Biochem. Pharmacol. 42:1991;1961-1968.
17. cdc2 kinase. Proc. Am. Assoc. Cancer Res. 34:1993;291.
18. 3 (or menadione): antitumour activity and mechanism of action. The Proceedings of the First International Congress on "Vitamins and Biofactors in Life Science". Kobe, Japan, 1991, 1, 75.
19. Chang L.-P., Wu F.Y.-H. Dephosphorylation of retinoblastoma protein induced by gamma radiation correlates with cell cycle perturbation. Oncol. Reports. 1:1994;503-506.
20. cdc2 kinase and phosphatase. Biochem. Biophys. Res. Commun. 190:1993;907-913.
21. 3 induces cell death via apoptosis in human cervical carcinoma TSGH8302 cells. Oncol. Reports. 1:1994;53-58.
22. 3-induces cell cycle arrest and apoptotic cell death are accompanied by altered expression of c-fos and c-myc in nasopharyngeal carcinoma cells. Oncogene. 8:1993;2237-2244.
23. Brown P.C., Dulik D.M., Jones T.W. The toxicity of menadione (2-methyl-1,4-naphthoquinone) and two thioether conjugates studied with isolated renal epithelial cells. Arch. Biochem. Biophys. 285:1991;187-196.
24. Ross D., Thor H., Orrenius S., Mold'eus P. Interaction of menadione (2-methyl-1,4-naphthoquinone) with glutathione. Chem. Biol. Interact. 55:1985;177-184.
25. Gant T.W., Rao D.N.R., Mason R.P., Cohen G.M. Redox cycling and sulphydryl arylation; their relative importance in the mechanism of quinone cytotoxicity to isolated hepatocytes. Chem. Biol. Interact. 65:1988;157-173.
26. 3 oxide inhibit growth of Hep3B and HepG2 cells. Bioorg. Chem. 23:1995;101-108.
27. Nishikawa Y., Carr B.I., Wang M.et al. Growth inhibition of hepatoma cells induced by vitamin K and its analogs. J. Biol. Chem. 270:1995;28304-28310.
28. Cantoni O., Fiorani M., Cattabeni F., Bellomo G. DNA breakage caused by hydrogen peroxide produced during the metabolism of 2-methyl-1,4-naphthoquinone (menadione) does not contribute to the cytotoxic action of the quinone. Biochem. Pharmacol. 42(Suppl.):1991;S220-S222.
29. Ham S.W., Park H.J., Lim D.H. Studies on menadione as an inhibitor of the cdc25 phosphatase. Bioorg. Chem. 25:1997;33-36.
30. Smith P.K., Krohn R.I., Hermanson G.T.et al. Measurement of protein using bicinchoninic acid Anal. Biochem. 150:1985;76-85.
31. Hoffmann I., Draetta G., Karsenti E. Activation of the phosphatase activity of human cdc25A by a cdk2-cyclin E dependent phosphorylation at the G1/S transition. EMBO J. 13:1994;4302-4310.
32. Gabrielli B.G., Clark J.M., McCormack A.K., Ellem K.A.O. Ultraviolet light-induced G2 phase cell cycle checkpoint blocks cdc25-dependent progression into mitosis. Oncogene. 15:1997;749-758.
33. Sherr C.J., Roberts J.M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1995;1149-1163.
34. 3) enhances the mitogenic signal of epidermal growth factor via extracellular signal-regulated kinases. Int J Oncol. 13:1998;1163-1170.